Lv7173
4380 积分 2021-10-09 加入
Association of NRAS mutations and tertiary lymphoid structure formation with clinical outcomes of adjuvant PD-1 inhibitors for acral melanoma
7天前
已完结
Adjuvant treatment with anti‐PD‐1 in acral melanoma: A nationwide study
7天前
已完结
Adverse events associated with postoperative outcomes of adjuvant anti‐PD‐1 antibody therapy in both acral and non‐acral cutaneous melanomas: A multicenter, observational, post hoc analysis study
7天前
已完结
Impressive response to dabrafenib and trametinib plus silybin in a heavily pretreated IDH wild-type glioblastoma patient with BRAFV600E-mutant and SOX2 amplification
30天前
已完结
The new IASLC grading system for invasive non‐mucinous lung adenocarcinoma is a more useful indicator of patient survival compared with previous grading systems
1个月前
已完结
Rechallenge treatment with a platinum-based regimen in patients with sensitive relapsed small-cell lung cancer
1个月前
已完结
Novel therapeutic strategies for recurrent SCLC
1个月前
已完结
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study
1个月前
已完结
Real-world surgical treatment patterns and clinical outcomes in patients with stages IA–IIIA non-small cell lung cancer: a retrospective multicentric observational study involving 11,958 patients
2个月前
已完结
皖公网安备34019202002308
